<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02992756</url>
  </required_header>
  <id_info>
    <org_study_id>1607-BIO-057-MF</org_study_id>
    <nct_id>NCT02992756</nct_id>
  </id_info>
  <brief_title>Influence of Needling Rich Plasma Growth Factors in Ovaries in Assisted Reproductive Techniques</brief_title>
  <official_title>Prospective Interventional Test on the Activity of PRGF (Rich Plasma in Growth Factors) Administered by Direct Ovarian Puncture in Patients With Low Follicular Reserve Submitted to Assisted Reproduction Treatments.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IVI Bilbao</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IVI Bilbao</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Assisted reproduction patients candidates to an IVF/ICSI cycle with low follicular reserve:
      after at least one cycle of stimulation obtaining 0-4 oocytes.

      Improve the follicular response in patients with low response, increasing the number of
      follicles in subsequent cycles to treatment with growth factors.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2017</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of follicles recruited after instability of ovarian growth factors</measure>
    <time_frame>two months; Time included in two protocols of ovarian stimulation</time_frame>
    <description>increasing the number of follicles in subsequent cycles to treatment with growth factors.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>rates of pregnancy rates</measure>
    <time_frame>three months after embryo transfer after treatment of growth factors</time_frame>
    <description>Increase pregnancy rates and decrease the number of cycles of accumulation of oocytes.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">51</enrollment>
  <condition>Low Ovarian Reserve</condition>
  <arm_group>
    <arm_group_label>PRP patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients candidates to an IVF/ICSI cycle with low follicular reserve: after at least one cycle of stimulation obtaining 0-4 oocytes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No PRP patients</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients candidates to an IVF/ICSI cycle with low follicular reserve: after at least one cycle of stimulation obtaining 0-4 oocytes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Growth Factors</intervention_name>
    <description>one dose
1 mL of PRP obtained by PRGF Endoret</description>
    <arm_group_label>PRP patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients candidates to an IVF/ICSI cycle with low follicular reserve: after at least
             one cycle of stimulation obtaining 0-4 oocytes.

        Exclusion Criteria:

          -  Ovarian inaccessibility

          -  Single ovary

          -  III-IV Endometriosis

          -  Adherence syndrome

          -  Older than 42 years

          -  Previous history of Pelvic Inflammatory Disease

          -  Risk of infection
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>49 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>IVI Bilbao</name>
      <address>
        <city>Leioa</city>
        <state>Vizcaya</state>
        <zip>48940</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 2, 2016</study_first_submitted>
  <study_first_submitted_qc>December 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 14, 2016</study_first_posted>
  <last_update_submitted>August 21, 2017</last_update_submitted>
  <last_update_submitted_qc>August 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitogens</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

